Suppliers of dna polymerase in pcr are also being affected by the rapid deterioration of the global pandemic
Transmission of the Novel coronavirus variant omicronxin subtype BA.5 has accelerated. The cumulative number of confirmed cases in the United States is now close to 90 million. According to the CENTERS for Disease Control and Prevention (CDC), the national epidemic worsened rapidly in the week ending July 16 compared to the previous week. A total of 1,143 counties across the United States are now classified as high-risk for COVID-19 by the CDC, a 71% increase from the previous week, and more than half of the U.S. population is at high risk.
According to the Kyodo News agency, the number of infections across Japan has surged since July, with the seventh full wave of the epidemic hitting, and it is impossible to predict when it will peak. Reports say the surge in infections is due to the rapid spread of Omicron BA.5. In addition, the diminishing protective effect of vaccines over time is also a factor in the increase in cases.
Mexico is facing the fifth peak of the epidemic nationwide, with the Mexican Ministry of Health predicting the epidemic will peak on July 17. The Mexican government is urging people to continue to take good personal hygiene precautions and continue to promote COVID-19 vaccination across the country.
Peru's Health Minister Ricardo Lopez predicted on Sunday that several thousand people could die in the fourth wave of COVID-19 infections in the country, The Public Newspaper reported. Lopez reiterated her call for timely vaccination against the novel Coronavirus.
There are now 539 confirmed cases of monkeypox across Canada, up 62 cases from 477 two days ago, according to the Public Health Agency of Canada.
Overview of market area prospect of dna polymerase in pcr
By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa (MEA). North America is further divided into countries such as the United States and Canada. The European region is further divided into The United Kingdom, France, Germany, Italy, Spain, Russia and the rest of Europe. The Asia Pacific region is further subdivided into China, Japan, Korea, India, Australia, Southeast Asia and the rest of Asia Pacific. The Latin America region is further subdivided into Brazil, Mexico and the rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa and the rest of MEA.
Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables or dna polymerase in pcr . Send an email to: email@example.com and our professional sales engineer will get back to you within 48 hours.
Analysis and forecast of the market size of PCR diagnostic industry
Polymerase chain reaction (PCR) is a nucleic acid synthesis technology that uses the principle of DNA double-strand replication to replicate specific DNA fragments in vitro. With this technology, the detection equipment can amplify the target gene in a large number in a short time, expanding the target gene fragment to the order of millions to billions, thus achieving high sensitivity detection. At present, polymerase chain reaction (PCR) diagnosis of infectious diseases such as hepatitis, venereal disease, intestinal respiratory disease and tumor single gene detection is an important application field. In 2020, polymerase chain reaction (PCR) diagnostic technology was identified as the "gold standard" for COVID-19 diagnosis due to its high sensitivity and accuracy.
China's PCR diagnostic market is developing rapidly, with the market size growing rapidly from about RMB 2.37 billion in 2015 to about RMB 5.93 billion in 2019, with a compound annual growth rate of 25.8%. China's PCR industry experienced explosive growth due to the huge demand for testing caused by the outbreak of COVID-19 in 2020, and the market size of China's PCR diagnostic industry exceeded 10 billion yuan in 2020. With the introduction of a large number of PCR diagnostic instruments, the PCR diagnostic industry will enter a new stage of development. It is expected that the PCR diagnostic industry will maintain a double-digit growth rate, and the market size of the PCR diagnostic industry will reach about 23.42 billion yuan in 2030 based on the factory price, and the cagR will reach about 13.3% from 2019 to 2030.
Market Demand of the dna polymerase in pcr
The DNA/RNA Extraction Kit market and other dna polymerase in pcr s are projected to grow at a CAGR of 8.26% during the forecast period 2022-2027.
The COVID-19 pandemic has impacted the dna polymerase in pcr market for a short time due to restrictions on different business and research activities for dna polymerase in pcr s. In addition, diagnostic tests for other diseases and medical conditions in hospitals and other clinical diagnostic facilities have been affected as COVID-19 has led to fewer patients taking tests. However, the high rate of COVID-19 infection and research activities are undertaken by major companies in the field of sequencing to expand their understanding of the virus and its origins, as well as molecular diagnostics of the SARS-COV-2 virus, have led to the development and launch of many DNA - and RNA-BASED COVID-19 kits, The kits proved so important that they were in great demand.
Market drivers for the dna polymerase in pcr
The growth of the DNA/RNA extraction kit market is primarily driven by increased investment in R&D activities in different areas, including molecular diagnostics for different chronic and infectious diseases. For example, the US spent $842 billion on R&D activities in 2020, followed by China at $664 billion, according to the ORGANISATION for Economic Co-operation and Development. Technological advances worldwide, new product launches by major market players, and an increase in cancer cases are also likely to complement the growth of the markets under study.
Other factors, such as increased demand for automation of DNA/RNA extraction technologies, new user-friendly and easy extraction kits, and DNA/RNA for analysis of new diseases causing microorganisms, are expected to drive DNA/RNA growth. RNA Extraction Kit market during the forecast period. Therefore, low awareness and availability of the kit and low market penetration in less developed and developing regions around the world are the major factors limiting the growth of the DNA/RNA extraction kit market.
North America is expected to dominate the global dna polymerase in pcr market during the forecast period
North America, which holds a major share in the dna polymerase in pcr market, is expected to show a similar trend during the forecast period, mainly due to the high level of R&D activity in the region and the presence of major market players in the region constantly developing their products for the markets studied.
In the region, the US is expected to take a major share of the DNA/RNA extraction kit market due to heavy investment in R&D by government and private entities, increased demand for dna polymerase in pcr s, and the rising prevalence of chronic diseases.
The dna polymerase in pcr professional supplier manufacturer -Geneture
Geneture is a professional supplier of Nucleic Acid Extraction Reagent,Automatic Nucleic Acid Extraction,Lab consumables, Real-time PCR, Covid-19 Rapid Test Supplier. Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables.
15+ years of experience
Over $50+ million in sales
14+ years of experience
Over $50+ million in sales
About Metal Alloy High Purity Tungsten Crucibles:Chemical composition:…
About Metal Alloy Vacuum Coating Tungsten Melting Pot Tungsten Crucibles:Chemical composition:…